Dhampur Bio Organics Limited disclosed that its promoter, Sonitron Limited, increased its stake in the company through open market purchases on July 24 and July 27, 2026. The acquisitions were made in compliance with Regulation 29(2) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The increase in promoter holding signals continued confidence in the company’s long-term prospects, as Sonitron added nearly 9,300 shares to its existing portfolio within a three-day window.

The disclosure was submitted to both the Bombay Stock Exchange and the National Stock Exchange of India Limited on July 28, 2026. Ashu Rawat, Company Secretary and Compliance Officer of Dhampur Bio Organics Limited, signed the intimation on behalf of the listed entity. Mukul Sharma, Director of Sonitron Limited, signed the underlying disclosures confirming the acquisition details and affirming that the acquirer belongs to the promoter group.

Shareholding Changes

Sonitron Limited executed two separate open market purchases during the period. The first transaction occurred on July 24, 2026, when the promoter acquired 3,719 equity shares. This purchase increased its holding from 1,14,71,231 shares to 1,14,74,950 shares, representing a rise in stake from 17.279% to 17.285% of the total voting capital.

A second acquisition followed on July 27, 2026, where Sonitron purchased an additional 5,549 equity shares. This move further elevated its total holding to 1,14,80,499 shares, corresponding to 17.293% of the total voting capital. No warrants, convertible securities, or encumbrances were involved in these transactions.

Capital Structure Context

The total equity share capital of Dhampur Bio Organics Limited remained unchanged at 6,63,87,590 equity shares of ₹10 each during these transactions. The total diluted share/voting capital also stood at 6,63,87,590 equity shares, indicating no outstanding convertible instruments that would alter the denominator for stake calculations. The disclosures referenced Regulation 31 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the base capital figures.

What the Numbers Show

The incremental nature of the purchases suggests a steady accumulation strategy rather than a large block trade. By increasing its stake by approximately 0.014 percentage points across two days, Sonitron Limited reinforced its position as the primary promoter without triggering open offer thresholds under the Takeover Code. The absence of encumbrances on the acquired shares indicates clean title transfer, adding to the quality of the promoter’s holding.

Dhampur Bio Organics Limited shareholders approved a final dividend of ₹1.50 per equity share and re-designated Gautam Goel as Chairman and CEO during its 6th Annual General Meeting held on July 24, 2026. The meeting, conducted via video conferencing, saw the passage of all 11 resolutions with overwhelming support from promoter groups, solidifying governance changes following the slump sale of the Meerganj unit.

The meeting commenced at 4:00 PM IST with a quorum present through virtual attendance. Saket Sharma of M/s GSK & Associates served as the scrutinizer, submitting his consolidated report on July 25, 2026. The statutory auditors, M/s Mittal Gupta & Company, were re-appointed for a second five-year term. Remote e-voting was active from July 20 to July 23, 2026, while e-voting at the AGM allowed additional participation for those who had not voted remotely.

Key Resolutions Passed

Shareholders voted on four ordinary business items and seven special business items. All resolutions received majority approval, driven by near-unanimous support from the promoter group.

Voting Analysis

Promoter and Promoter Group shareholders, holding 33,714,207 shares, cast 99.74% of their eligible votes. They voted in favor of all resolutions except for the re-appointment of Gautam Goel by rotation and his re-designation as CEO, where participation was lower but still resulted in unanimous support among votes cast. Public non-institutional shareholders showed dissent on specific governance changes; approximately 4.27% voted against the AOA amendment, while 4.54% opposed the CEO re-designation. However, these dissenting votes did not impact the passage of any resolution.

Governance Updates

The special resolution to amend the Articles of Association by inserting new Article 125A passed with 99.99% support. Additionally, shareholders approved amendments to the terms of gratuity payment to directors, which received 99.86% support. The remuneration revisions for General Managers Maayashree Goel and Meerashree Goel were also approved, each garnering 99.89% support. The company ratified the payment of commission to non-executive directors for FY26, passing with 99.99% approval.